Bye CFDA: China's drug regulator to take new shape in major government restructuring
A sweeping government reorganization has rewoven the China Food and Drug Administration into the fabric of an overarching market supervision administration, giving birth to a drug regulator under its purview.
The changes mean that after five years of directly reporting to the State Council, the CFDA will no longer be a standalone agency. The newly created market supervision administration will have a broad mandate covering anti-monopoly laws, price control, consumer goods quality and safety, etc — and that includes everything food-related. It will, however, leave the matters of drug approval to a sub-administration dedicated to drug regulation.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.